$EW
AI分析生成日 May 11, 2026
AI Score
Hold$EW
Edwards Lifesciences
$EWNYSEHealthcareLarge-Cap
Edwards Lifesciences develops transcatheter heart valve replacement and hemodynamic monitoring products.
Market Cap
$42.0B
Revenue (TTM)
$6.1B
+8.0%
Net Income (TTM)
$1.5B
+12.0%
EPS (TTM)
$2.50
P/E Ratio
32.0
Dividend Yield
0.0%
52-Week Range
$55-$95
Beta
0.95
Dimension Scores
Fundamental
72Technical
66Sentiment
68Risk / Reward
72Momentum
66Financial Health
Profitability
77strong
Growth
69moderate
Liquidity
80strong
Solvency
74strong
Efficiency
70strong
Valuation, technical analysis, investment thesis, risk assessment and more for $EW
Free · No credit card required
免責事項: AI生成の分析は教育目的のみです。投資アドバイスではありません。必ず資格のあるファイナンシャルアドバイザーにご相談ください。